Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

U.S. Senators Re-Introduce Bill to Allow Drug Importation from Canada

New York, NY, January 9, 2015 ― Pharmalot today reported that, in their latest bid to lower prescription drug costs, two U.S. Senators have re-introduced legislation that would allow Americans to purchase medicines from Canada.

This marks the second consecutive year that Amy Klobuchar (D-Minn.) and John McCain (R-Az.) have advocated the Safe and Affordable Drugs from Canada Act.

According to the Pharmalot report, the bill, if passed and signed into law, would permit Americans, who must have a valid prescription from a physician licensed in the U.S., to order up to a 90-day supply of medicines from a licensed Canadian pharmacy.  Prescription drugs would have to have the same active ingredients, dosage form, and potency as medicines that are approved by the FDA.

Whether the legislation will progress is uncertain.  The bill introduced last year went nowhere, despite bi-partisan sponsorship.

Pharmalot, a Wall Street Journal blog and a rich source of biopharma sector news, explores the fast-moving, complicated world that develops and markets medicines — and the drug makers that are attempting to replenish their pipelines while grappling with pricing and regulatory dictates, among many other challenges.

For the full Pharmalot story, click here.  You may also follow Pharmalot on Twitter at @Pharmalot.